Moreover, heightened expression of estrogen receptors (ERs) has been associated with diminished infiltration of CD8+ T cells and reduced expression of PD-1/PD-L1 in breast cancer cells by suppressing IL-17 signaling and impeding Th17 cell infiltration (85). This evidence concerns the gene ESR1 and breast carcinoma.